发现一种强效的二胺衍生物作为一种新的BRD4降解剂
Mayu Shigekuni1, Yasuki Niwa1, Kiyomi Ohba1
1Research Division, Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan.
Bioorganic & medicinal chemistry
|February 26, 2026
概括
研究人员开发了用于癌症治疗的新型马素含蛋白4 (BRD4) 降解剂. 这些新化合物基于二胺支架,显示出强大的抗瘤作用,特别是在急性髓性白血病模型中.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 含有odomain的蛋白4 (BRD4) 是一个关键的表观遗传调节器,与各种癌症有关.
- Y-803 (比拉布雷西布,OTX015/MK-8628) 是一类第一的BRD4抑制剂,在其二胺基架周围建立了结构-活性关系 (SAR).
研究的目的:
- 设计和优化基于希佩尔-林道 (VHL) 的新型BRD4降解器.
- 评估这些新型降解剂的抗瘤疗效,特别是在急性髓性白血病 (AML) 中.
主要方法:
- 利用来自Y-803的二二胺支架的内部SAR数据.
- 设计和合成基于VHL的BRD4降解器.
- 在AML异种移植模型中测试降解剂的有效性.
主要成果:
- 一个新的,最好的BRD4降解器成功设计和优化.
- 开发的降解剂在临床前模型中表现出强大的抗瘤活性.
- 二胺基基架被证明可以开发基于VHL的降解剂.
结论:
- BRD4降解剂代表了一种有前途的新型抗瘤治疗药物.
- 新型BRD4降解剂显示出治疗AML的巨大潜力.
- 这项工作验证了基于VHL的降解剂策略,使用二胺支架.
相关概念视频
Drug Discovery: Overview
12.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.3K
Diazonium Group Substitution: –OH and –H
3.4K
Nitrous acid, a weak acid, is prepared in situ via the reaction of sodium nitrite with a strong acid under cold conditions. This nitrous acid prepared in situ reacts with primary arylamines to form arenediazonium salts. Such reactions are known as diazotization reactions. As shown in Figure 1, the formation of arenediazonium salts begins with the decomposition of nitrous acid in an acidic solution to give nitrosonium ions.
3.4K
Sedatives and Hypnotics Drugs: Benzodiazepines
1.1K
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.1K
Phase I Reactions: Reductive Reactions
667
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
667
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
2.6K
Arenediazonium substitution reactions occur when the diazonium group is substituted by various functional groups such as halides, hydroxyl, nitrile, etc. For instance, arenediazonium salts react with copper(I) salts of chloride, bromide, or cyanide to form corresponding aryl chlorides, bromides, and nitriles. These reactions are named Sandmeyer reactions. Although the mechanism of this reaction is complicated, as illustrated in Figure 1, they are believed to progress via an aryl copper...
2.6K
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
6.9K
All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.9K


